THE ALUMINUM CONUNDRUM: UNVEILING THE CONTROVERSIAL USE AND POTENTIAL DANGERS IN PERSONAL CARE PRODUCTS
INTRODUCTION
Aluminum, the most abundant metallic element in the Earth’s crust, is widely used in a variety of personal care products, notably in antiperspirants and deodorants. Its utility lies in its effectiveness in inhibiting perspiration; however, recent years have seen a surge in concerns regarding the potential health risks associated with aluminum, particularly in its correlation with Alzheimer’s disease, breast cancer, and its impact on the thyroid and lymphatic systems. This white paper aims to explore some of the available research and provide an overview of the potential health implications of aluminum in personal care products.
ALUMINUM IN PERSONAL CARE PRODUCTS
The introduction of aluminum-based compounds into personal care products, notably antiperspirants, traces back to the early 20th century, marking a significant advancement from the previously used methods like talc, starch-based products, and natural astringents such as witch hazel. Aluminum chlorohydrate, the primary compound used in antiperspirants, functions by temporarily blocking sweat pores, effectively reducing perspiration. Beyond antiperspirants, aluminum’s utility extends to various other personal care categories, including certain cosmetics for their pigment- binding properties, toothpaste for color and abrasiveness, and some sunscreens for UV reflection. However, the widespread adoption of aluminum in these products has not been without controversy. Concerns have been raised regarding potential health implications, including links to breast cancer and Alzheimer’s disease, as well as skin irritation in sensitive individuals. These concerns have spurred interest in alternative ingredients, leading to the development of products with natural mineral salts and plant-based antibacterial properties. The evolution of aluminum’s use in personal care products reflects ongoing scientific research and shifting consumer preferences towards safer and more natural products.
RESEARCH ON ALUMINUM AND HEALTH IMPLICATIONS
The exploration of a potential link between aluminum exposure and Alzheimer’s disease has been a focal point of neuroscientific research for many years. This interest is rooted in the observation of aluminum deposits in the brains of Alzheimer’s patients, leading to hypotheses about its possible role in the pathogenesis of neurodegenerative diseases. Notably, the study conducted by Walton in 2006, as published in the “Journal of Alzheimer’s Disease,” shed light on this association, suggesting that aluminum accumulation in the brain might contribute to Alzheimer’s pathology. Walton’s research pointed to the neurotoxic potential of aluminum and its ability to induce cognitive impairments akin to those observed in Alzheimer’s disease.
In 1989, research published in a groundbreaking study in the “Lancet” that found a geographical association between Alzheimer’s disease and aluminum in drinking water. Researchers discovered that the risk of Alzheimer’s disease was 1.5 times higher in areas where the mean aluminum concentration in water exceeded 0.11 mg/L compared to areas with lower concentrations.
Since then, numerous studies have been conducted to explore this intriguing relationship further. For instance, Rondeau and his team conducted an 8-year-up study in 2000 and found that the risk of Alzheimer’s disease was indeed higher in districts with higher aluminum concentrations in water.
Despite these findings, the scientific community remains divided on the issue. The Alzheimer’s Association, a leading authority on dementia- related research, references a substantial body of studies that have yet to establish a definitive causal link between aluminum and Alzheimer’s disease. This position is supported by a review of existing literature, which indicates that while aluminum exposure may have some neurotoxic effects, a direct connection to Alzheimer’s disease is not conclusively proven. For example, a comprehensive review by Yokel and McNamara in 2001, published in the “Brain Research Bulletin,” argued that available data did not convincingly support the hypothesis that aluminum exposure is a significant risk factor for Alzheimer’s disease.
BREAST CANCER
Similarly, the implications of aluminum on breast cancer have been a subject of extensive research, given the widespread use of aluminum-based compounds in antiperspirants and their proximity to the breast area. Philippa D. Darbre’s 2005 study, published in the “Journal of Inorganic Biochemistry,” explores the presence of aluminum in breast tissue and its potential role in breast cancer development, discussing how aluminum compounds might mimic estrogen, a hormone known to influence breast cancer growth. The study also considers geographical variations in breast cancer incidence and its potential connection to aluminum-based antiperspirant usage. Complementing this, a 2007 study by Exley et al., in the same journal, measured the concentration of aluminum in human breast tissue, finding higher levels in the outer breast compared to the inner regions, raising concerns about aluminum accumulation from antiperspirant use. Adding to this discourse, Linhart et al.’s 2017 study in “EBioMedicine” investigated the relationship between underarm cosmetic product use and breast cancer risk. This study suggested a potential association between the frequency and onset of antiperspirant/deodorant use and an increased risk of breast cancer but also emphasized the necessity for further research to establish any causal relationship. An additional element of significant concern regarding women’s health is the neurodevelopmental impact of aluminum. Bishop et al. (1997) in the “Lancet” reported potential neurotoxic effects of aluminum in preterm infants. This has raised questions about the safety of aluminum in medications and products used by infants and pregnant women.
IMPACT ON THE LYMPHATIC AND THYROID SYSTEMS
The potential impact of aluminum on the lymphatic and thyroid systems has been an area of emerging interest in medical research. While the use of aluminum-based compounds in products like antiperspirants is widespread, concerns about their systemic effects, particularly on the lymphatic and thyroid systems, are growing.
The proximity of antiperspirant application to the lymph nodes in the underarm area has raised concerns about the possible absorption of aluminum and its effects on the lymphatic system. The lymphatic system, crucial for immune function and waste removal, could be susceptible to the accumulation of aluminum, potentially leading to lymphatic dysfunction. However, research in this specific area remains limited. A study by Flarend et al. in “Food and Chemical Toxicology” tracked aluminum absorption from antiperspirants and found that a very small percentage was absorbed into the bloodstream, indicating a potential for accumulation in the body, including the lymphatic system.
The thyroid gland is known for its sensitivity to environmental toxins, including heavy metals like aluminum. Some studies have suggested that exposure to aluminum could disrupt thyroid function, potentially leading to thyroid disorders. Research by Ryabukhin in “Soviet Medical Reviews” series on Toxicology highlighted the accumulation of aluminum in the thyroid gland and its possible role in thyroid dysfunction. However, these findings are often based on scenarios of high environmental exposure or occupational exposure, which may not directly correlate to the everyday use of aluminum-containing antiperspirants.
CONCLUSION
While aluminum’s efficacy in personal care products is well-documented, the ongoing debate and emerging research on its potential health risks call for a cautious approach. The correlations with Alzheimer’s disease, breast cancer, thyroid, and lymphatic system implications remain areas of active research. The efficacy of natural ingredients in deodorants has been recognized as a viable alternative to conventional products, particularly for those concerned about the potential health risks associated with aluminum compounds. These natural-based products offer a dual function of controlling body odor and providing skin benefits, making them increasingly popular in the personal care market. As the demand for natural and organic products continues to grow, it’s likely that more innovative and effective natural deodorant formulations will emerge. Consumers and health professionals should stay informed about the latest findings and make choices that best suit their health needs and concerns.
REFERENCES
1 Walton, J. R. (2006). Aluminum in Hippocampal Neurons from Humans with Alzheimer’s Disease. Journal of Alzheimer’s Disease, 10(2-3), 175-180.
2 Martyn, C. N., et al. (1989). Geographical Relation Between Alzheimer’s Disease and Aluminum in Drinking Water. The Lancet.
3 Yokel, R. A., & McNamara, P. J. (2001). Aluminium in Alzheimer’s disease: are we still at a crossroad? Brain Research Bulletin, 55(2), 147-160.
4 Alzheimer’s Association. (n.d.). Myths About Alzheimer’s Disease. Retrieved from Alzheimer’s Association website
5 Darbre, P. D. (2005). Aluminium, antiperspirants and breast cancer. Journal of Inorganic Biochemistry, 99(9), 1912-1919.
6 Exley, C., Charles, L. M., Barr, L., Martin, C., Polwart, A., & Darbre, P. D. (2007). Aluminium in human breast tissue. Journal of Inorganic Biochemistry, 101(9), 1344-1346.
7 Linhart, C., Talasz, H., Morandi, E. M., Exley, C., Lindner, H. H., Taucher, S., Egle, D., Hubalek, M., Concin, N., & Ulmer, H. (2017). Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer: A Case-Control Study. EBioMedicine, 21, 79-85.
8 Flarend, R., Bin, T., Elmore, D., & Hem, S. L. (2001). A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food and Chemical Toxicology, 39(2), 163-168.
9 Ryabukhin, Y. S. (1978). Aluminium and the Thyroid Gland: A Review of the Literature. Soviet Medical Reviews, Series on Toxicology.
10 Bishop, N. J., Morley, R., Day, J. P., & Lucas, A. (1997). Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. The Lancet, 349(9060), 1167-1171.
ABOUT THE AUTHORS
Matthew Frederick
Instagram: @matthew_frederick_official
X: @matthew_frederick_official
LinkedIn: https://www.linkedin.com/in/matthew-frederick-nobiesse/
Matthew Frederick is President and CEO of Nobiesse Laboratories. His work is focused on exploring the boundaries of wellness, health and longevity and to developing high-quality, personalized products and services that can help people to live longer, happier, more fulfilled lives. He created Nobiesse to address a fundamental lack of quality Do-No-Harm products in the consumer market and to lead a charge to transform broken consumer care, medical and financial models around the world. Frederick holds an BS from Northeastern University and has completed the Executive Development Program at The Wharton School at the University of Pennsylvania. He is based in Parsippany, New Jersey.
Instagram: @NobiesseLabs
X: Follow @NobiesseLabs
About Nobiesse Insights
Nobiesse Insights publishes original articles, research summaries and opinion papers that provide insights for consumers. Our goal is to draw upon published clinical research and experience from throughout our professional services organizations, and that of clinical researchers and practitioners in academia and business, to advance the conversation through critical exploration of clinical research and thought leadership on a broad spectrum of topics of interest to people seeking to improve their nutritional, health, financial and longevity awareness. Nobiesse Insights is an imprint of Nobiesse Laboratories, LLC.
About this publication
This publication contains general information only, and none of Nobiesse Laboratories, LLC, its member firms, or its and their affiliates or their respective employees or associates are, by means of this publication, rendering nutritional, medical, accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your health, finances or your business. Before making any decision or taking any action that may affect your health, finances or your business, you should consult a qualified professional adviser or medical professional.
None of Nobiesse Laboratories, LLC, its member firms, employees, or its and their respective affiliates shall be responsible for any loss or injury whatsoever sustained by any person who relies on this publication.
About Nobiesse
Nobiesse refers to one or more of Nobiesse Laboratories, LLC, its network of member firms, and their related entities. Nobiesse and each of its related entities are legally separate and independent entities. Nobiesse Laboratories, LLC (also referred to as “Nobiesse”) does not provide services to clients. In the United States, Nobiesse refers to one or more of the US member firms of Nobiesse Laboratories, LLC, their related entities that operate using the “Nobiesse” name in the United States and their respective affiliates. Certain services may not be available to customers and clients in all areas. Please see www.nobiesse.com to learn more about our global network of related entities.
Disclaimer: The information provided in this white paper is intended for informational and educational purposes only and is not intended to constitute nutritional, medical, or financial advice. This information has not been evaluated by the Food and Drug Administration (FDA), and the content presented here is not intended to diagnose, treat, cure, or prevent any medical condition or disease. Readers are encouraged to seek advice from a qualified physician or healthcare provider for medical concerns or conditions. The authors and publishers of this white paper do not endorse or recommend specific nutritional, medical, or treatments, therapies, or interventions, or specific financial investment options, products or programs. Any decisions regarding medical treatment should be made in consultation with a licensed healthcare professional. Any decisions regarding financial investments, financial planning, or tax-related questions should be made in consultation with a licensed finance professional. This information is not a substitute for professional medical advice, diagnosis, or treatment, and the FDA has not reviewed or approved any claims made in this white paper.
Copyright Nobiesse Laboratories, LLC 2023. All Rights Reserved. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons License, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless otherwise indicated in a credit line to the material. If material is not included in the article’s Creative Commons license, and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
